GSEP
DGX icon

Golden State Equity Partners’s Quest Diagnostics DGX Stock Holding History

Golden State Equity Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,428
Closed -$280K – 681
2026
Q1 		$280K Buy
1,428
+181
+15% +$35.2K 0.02% 594
2025
Q4 		$216K Sell
1,247
-13
-1% -$2.37K 0.03% 465
2025
Q3 		$240K Sell
1,260
-73
-5% -$13K 0.04% 394
2025
Q2 		$239K Sell
1,333
-170
-11% -$29.5K 0.04% 381
2025
Q1 		$254K Sell
1,503
-233
-13% -$38.3K 0.05% 366
2024
Q4 		$262K Sell
1,736
-521
-23% -$81K 0.05% 358
2024
Q3 		$350K Buy
2,257
+4
+0.2% +$597 0.05% 320
2024
Q2 		$308K Buy
+2,253
New +$309K 0.06% 313
2023
Q4 		$281K Buy
2,035
+251
+14% +$33K 0.07% 294
2023
Q3 		$217K Buy
1,784
+205
+13% +$27.3K 0.06% 301
2023
Q2 		$222K Buy
+1,579
New +$218K 0.06% 329

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Golden State Equity Partners's DGX Position: Q2 2026 in Review

Golden State Equity Partners sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 1,428 shares — an estimated $280K sold.

Golden State Equity Partners first reported a position in DGX in Q2 2023 and held it in 11 quarters. The position peaked at $350K in Q3 2024. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Golden State Equity Partners reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 1,428 Quest Diagnostics shares in Q2 2026, an estimated $280K.
  • Golden State Equity Partners first reported a position in Quest Diagnostics in Q2 2023 and held it in 11 quarters.
  • Golden State Equity Partners's Quest Diagnostics position peaked at $350K in Q3 2024.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.